Changes in serum calcitonin concentrations, incidence of medullary thyroid carcinoma, and impact of routine calcitonin concentration monitoring in the EXenatide Study of Cardiovascular Event Lowering (EXSCEL)
Retatrutide commercial availability timeline looks to late 2025 or early 2026 from present clinical trials and regulatory reviews
By committing to two or three workouts a week, prioritizing protein intake, and staying hydrated, patients can transform their health and build a resilient body
Institutional systems continue to favor Rx-classified nutritional therapies, which account for 81.6% of hospital-based supplement distribution
These medications carry a boxed warning about thyroid C-cell tumors (contraindicated with personal/family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2) and warnings about potential risks including pancreatitis, gallbladder disease, acute kidney injury with dehydration, and worsening diabetic retinopathy with rapid glucose reduction (particularly with semaglutide)
Track your burps for one week, noting when they occur relative to meals, injection timing, and activities